Comparison of Failure Rates for Intratympanic Dexamethasone and Gentamicin in Meniere's Disease

The setting of this study is at the Hospital of the University of Pennsylvania. A chart review of MD patients from 01/01/2005-10/25/2017 will be performed evaluating response and failure rates to IT therapies. The rationale for this study is to further evaluate failure rates to various IT therapies. The goal is to critically evaluate and compare rates of failure in MD patients to IT dexamethasone and IT gentamicin.

You may be eligible for this study if you meet the following criteria:

• Conditions: TBD, tbd, tbd
• Age: 99 years or below
• Gender: All